KalVista Pharmaceuticals Presents Positive Data on Sebetralstat for On-Demand HAE Treatment

KalVista Pharmaceuticals announced positive data from the KONFIDENT-S trial at the EAACI Congress 2025, showcasing sebetralstat's efficacy as an oral,...
Home/KnloSights/Clinical Trial Updates/KalVista Pharmaceuticals Presents Positive Data on Sebetralstat for On-Demand HAE Treatment